Device Trial Radar · NCT06365606
Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis Syphilis Ab Test at the Point- Of-Care Sites
Last checked: Nov 20, 2026Latest source record: Aug 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,500
Actual
Start
Mar 14, 2024
Primary completion
May 13, 2024
Study completion Jul 11, 2024
Sponsor
- Lead sponsor
- bioLytical LaboratoriesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 15, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Screening
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is a prospective cross-sectional study in which surgically non-invasive sample- taking is done only for the purpose of the study. Capillary (fingerstick) whole blood and plasma (i.e., obtained through venous EDTA whole blood collection and processing) are collected by a healthcare professional. The collected samples are tested in a routine testing environment, i.e., healthcare providers at
Conditions
- Syphilis Infection
- Syphilis
Interventions
iStatis Syphilis Ab TestDevice
Capillary (fingerstick) blood, venous whole blood and plasma samples prospectively collected from the participants will be tested on the iStatis Syphilis Ab Test.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sensitivity and specificity of the iStatis Syphilis Ab TestTime frame: 15 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Epicentre Health Research
Hillcrest, KwaZulu-Natal, South Africa
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.